Free Trial

Gyre Therapeutics (GYRE) Institutional Ownership

Gyre Therapeutics logo
$6.19 +0.50 (+8.79%)
Closing price 04:00 PM Eastern
Extended Trading
$6.19 0.00 (0.00%)
As of 06:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Gyre Therapeutics (NASDAQ:GYRE)

Current
Institutional Ownership
Percentage
23.99%
Number of
Institutional Buyers
(last 12 months)
17
Total
Institutional Inflows
(last 12 months)
$3.18M
Number of
Institutional Sellers
(last 12 months)
8
Total
Institutional Outflows
(last 12 months)
$922.73K
Get GYRE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Gyre Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

GYRE Institutional Buying and Selling by Quarter

Gyre Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/18/2026 Royal Bank of Canada5,605$39K0.0%-56.1%0.006%
5/7/2026 Dimensional Fund Advisors LP25,268$176K0.0%+131.8%0.026%
5/5/2026 Bank of New York Mellon Corp43,144$301K0.0%+4.7%0.044%
2/17/2026 State of Wisconsin Investment Board24,800$175K0.0%-36.4%0.026%
2/16/2026 Barclays PLC18,531$131K0.0%+38.3%0.019%
2/13/2026 Charles Schwab Investment Management Inc.169,158$1.19M0.0%+37.1%0.176%
2/13/2026 State Street Corp202,225$1.43M0.0%+10.7%0.210%
2/13/2026 Wells Fargo & Company MN12,919$91K0.0%+132.4%0.013%
2/12/2026 Dimensional Fund Advisors LP10,903$77K0.0%N/A0.011%
2/10/2026 Goldman Sachs Group Inc.31,108$220K0.0%+72.5%0.032%
2/9/2026 Geode Capital Management LLC423,222$2.99M0.0%+13.0%0.439%
2/3/2026 SBI Securities Co. Ltd.162,915$1.15M0.0%-2.9%0.169%
1/1/2026 JPMorgan Chase & Co.3,694$28K0.0%-42.8%0.004%
11/17/2025 Millennium Management LLC35,751$267K0.0%N/A0.037%
11/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.4,203$31K0.0%-43.3%0.004%
11/17/2025 Alliancebernstein L.P.21,830$163K0.0%+9.5%0.023%
11/14/2025 Lazard Asset Management LLC14,932$111K0.0%N/A0.016%
11/7/2025 JPMorgan Chase & Co.3,694$28K0.0%-42.8%0.004%
11/6/2025 Rhumbline Advisers13,432$100K0.0%-17.0%0.014%
11/5/2025 SBI Securities Co. Ltd.167,866$1.25M0.0%-27.7%0.174%
10/30/2025 Strs Ohio21,100$157K0.0%+58.6%0.022%
10/24/2025 State of Alaska Department of Revenue5,219$38K0.0%N/A0.005%
8/15/2025 Bank of America Corp DE6,277$46K0.0%+28.8%0.007%
8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.7,413$54K0.0%+77.8%0.008%
8/12/2025 American Century Companies Inc.11,291$83K0.0%-52.6%0.012%
8/12/2025 JPMorgan Chase & Co.6,461$47K0.0%+84.6%0.007%
8/8/2025 Geode Capital Management LLC401,709$2.95M0.0%+28.6%0.428%
8/8/2025 SBI Securities Co. Ltd.232,299$1.71M0.0%+87.9%0.248%
6/27/2025 Goldman Sachs Group Inc.16,147$125K0.0%-38.8%0.017%
5/16/2025Goldman Sachs Group Inc.16,147$125K0.0%-38.8%0.017%
5/14/2025Advantage Alpha Capital Partners LP13,663$105K0.0%+54.0%0.015%
5/13/2025American Century Companies Inc.23,825$184K0.0%N/A0.025%
5/9/2025Charles Schwab Investment Management Inc.111,416$860K0.0%-2.7%0.119%
5/2/2025SBI Securities Co. Ltd.123,629$954K0.0%+22.1%0.132%
4/29/2025Bank of New York Mellon Corp16,492$127K0.0%+18.7%0.018%
4/7/2025GAMMA Investing LLC1,822$140K0.0%+15,083.3%0.002%
2/17/2025Bank of America Corp DE6,937$84K0.0%+40.4%0.007%
2/14/2025Northern Trust Corp103,382$1.25M0.0%+9.1%0.111%
2/13/2025Barclays PLC10,543$128K0.0%+13.5%0.011%
2/13/2025Wells Fargo & Company MN4,016$49K0.0%+29.4%0.004%
The roadshow starts Monday. This stock isn't ready. (Ad)

The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the world's largest fund managers - including a section naming one small company Musk's Colossus cannot operate without. Right now, most fund managers have never heard of it. By Friday, every one of them will. Dylan Jovine has identified the name and ticker before $75 billion in new capital starts chasing the SpaceX supply chain.tc pixel

Get the stock name and ticker before the roadshow begins
2/11/2025Advantage Alpha Capital Partners LP8,873$107K0.0%-66.7%0.009%
2/6/2025Charles Schwab Investment Management Inc.114,566$1.39M0.0%+0.8%0.123%
2/6/2025SBI Securities Co. Ltd.101,239$1.23M0.0%N/A0.108%
2/4/2025Bank of New York Mellon Corp13,896$168K0.0%+11.1%0.015%
11/19/2024Barclays PLC9,288$116K0.0%+281.8%0.010%
11/16/2024Geode Capital Management LLC303,647$3.81M0.0%+16.9%0.325%
11/15/2024Barclays PLC9,288$116K0.0%+281.8%0.010%
11/15/2024State Street Corp104,490$1.31M0.0%+8.8%0.112%
11/13/2024FMR LLC3,742$47K0.0%N/A0.004%
11/13/2024Advantage Alpha Capital Partners LP26,634$334K0.1%N/A0.029%
11/12/2024Charles Schwab Investment Management Inc.113,648$1.43M0.0%+392.2%0.122%
8/14/2024Marshall Wace LLP10,720$128K0.0%-58.0%0.013%
8/9/2024Renaissance Technologies LLC13,900$166K0.0%N/A0.016%
8/9/2024WINTON GROUP Ltd18,467$220K0.0%N/A0.022%
8/1/2024Rhumbline Advisers10,291$123K0.0%N/A0.012%
7/26/2024Bank of New York Mellon Corp18,266$218K0.0%N/A0.021%
5/10/2024Vanguard Group Inc.195,098$3.41M0.0%-1.5%0.228%


GYRE Institutional Ownership - Frequently Asked Questions

During the previous two years, 28 institutional investors and hedge funds held shares of Gyre Therapeutics. The most heavily invested institutionals were Geode Capital Management LLC ($2.99M), State Street Corp ($1.43M), Northern Trust Corp ($1.25M), Charles Schwab Investment Management Inc. ($1.19M), SBI Securities Co. Ltd. ($1.15M), Bank of New York Mellon Corp ($301K), and Millennium Management LLC ($267K).Learn more on Gyre Therapeutics' institutional investors.

23.99% of Gyre Therapeutics' stock is owned by institutional investors. Learn more on GYRE's institutional investor holdings.

Of the 25 institutional investors that purchased Gyre Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: SBI Securities Co. Ltd. ($232.30K), Geode Capital Management LLC ($181.83K), Charles Schwab Investment Management Inc. ($137.25K), Millennium Management LLC ($35.75K), Advantage Alpha Capital Partners LP ($31.42K), State Street Corp ($27.88K), and Dimensional Fund Advisors LP ($25.27K).

Institutional investors have bought a total of 437,894 shares in the last 24 months. This purchase volume represents approximately $3.18M in transactions.

The following institutional investors have sold Gyre Therapeutics stock in the last 24 months: SBI Securities Co. Ltd. ($69.38K), State of Wisconsin Investment Board ($14.20K), American Century Companies Inc. ($12.53K), Goldman Sachs Group Inc. ($10.24K), Royal Bank of Canada ($7.16K), JPMorgan Chase & Co. ($5.53K), and MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. ($3.21K).

Institutional investors have sold a total of 125,015 shares in the last 24 months. This volume of shares sold represents approximately $922.73K in transactions.



This page (NASDAQ:GYRE) was last updated on 6/4/2026 by MarketBeat.com Staff.
From Our Partners